Public Sector Funds Contributed Up To 5 Times More Than J&J In Developing New TB Drug, Analysis Finds
STAT: Public funding underwrote much of the development of J&J’s drug for TB, analysis finds “Amid ongoing debate over taxpayer dollars used to generate medicines, a new analysis contends that public investments contributed up to five times more than what Johnson & Johnson (JNJ) spent to develop Sirturo, its groundbreaking…